Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.43 |
| ▸ | NOS3 | P29474 | 2/20 | 0.42 |
| ▸ | NOS1 | P29475 | 2/20 | 0.42 |
| ▸ | NOS2 | P35228 | 2/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | GRM5 | P41594 | 1/20 | 0.42 |
| ▸ | UHRF1 | Q96T88 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 5/20 | 0.39 |
| ▸ | HPGD | P15428 | 4/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | HTT | P42858 | 3/20 | 0.39 |
| ▸ | MITF | O75030 | 2/20 | 0.39 |
| ▸ | RAD52 | P43351 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29512854 | 1.00 | ALDH1A1 (0.43) | ALDH1A1TDP1TP53CYP3A4TSHR | |
| SCHEMBL9383607 | 0.79 | NCF1 (0.43) | ALDH1A1TDP1KDM4ENOS3NOS1 | |
| SCHEMBL5758060 | 0.79 | NOS2 (0.48) | ALDH1A1TDP1TP53CYP3A4TSHR | |
| SCHEMBL1279214 | 0.79 | KDM4E (0.54) | ALDH1A1TDP1TP53CYP3A4TSHR | |
| SCHEMBL19202623 | 0.75 | CYP3A4 (0.40) | ALDH1A1TDP1TP53CYP3A4TSHR | |
| SCHEMBL19203178 | 0.75 | ALDH1A1 (0.40) | ALDH1A1TDP1TP53CYP3A4TSHR | |
| SCHEMBL8062164 | 0.75 | NOS3 (0.39) | ALDH1A1TDP1CYP3A4KDM4ENOS3 | |
| SCHEMBL22030731 | 0.75 | NOS3 (0.39) | ALDH1A1TDP1KDM4ENOS3NOS1 | |
| SCHEMBL31211070 | 0.75 | NOS3 (0.39) | ALDH1A1TSHRKDM4ENOS3NOS1 | |
| SCHEMBL3886713 | 0.75 | POLB (0.53) | ALDH1A1TDP1TP53CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12613468-B2 | Method for forming patterned photoresist | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2026-04-28 | — | — | US | claimed |
| US-20240103375-A1 | METHOD FOR FORMING PATTERNED PHOTORESIST | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2024-03-28 | — | — | US | claimed |
| US-11886121-B2 | Method for forming patterned photoresist | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2024-01-30 | — | — | US | claimed |
| CN-115449284-B | Preparation method of antibacterial mildew-proof leather finishing agent containing plant-source-based efficacy factors | 四川大学 | 2023-05-16 | — | — | CN | claimed |
| CN-115449284-A | Preparation method of antibacterial and mildewproof leather finishing agent containing plant source-based functional factors | 四川大学 | 2022-12-09 | — | — | CN | claimed |
| US-20210063888-A1 | METHOD FOR FORMING PATTERNED PHOTORESIST | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2021-03-04 | — | — | US | claimed |
| WO-2013004617-A1 | PYRAZOLOPYRIDINES USEFUL IN THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM | H. LUNDBECK A/S (DK) | 2013-01-10 | — | — | WO | claimed |
| US-20130005743-A1 | New positive allosteric modulators of nicotinic acetylcholine receptor | H. LUNDBECK A/S (DK) | 2013-01-03 | — | — | US | claimed |
| US-12613468-B2 | Method for forming patterned photoresist | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2026-04-28 | — | — | US | disclosed |
| EP-4656602-A2 | MEMBRANES FOR REMOVING METALLIC SPECIES FROM AMINES | Entegris, Inc. (US) | 2025-12-03 | — | — | EP | disclosed |
| US-20240350984-A1 | MEMBRANES FOR REMOVING METALLIC SPECIES FROM AMINES | ENTEGRIS, INC. | 2024-10-24 | — | — | US | disclosed |
| US-12059656-B2 | Membranes for removing metallic species from amines | ENTEGRIS, INC. (US) | 2024-08-13 | — | — | US | disclosed |
| US-20240103375-A1 | METHOD FOR FORMING PATTERNED PHOTORESIST | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2024-03-28 | — | — | US | disclosed |
| EP-3532474-B1 | 4,5-ANNULATED 1,2,4-TRIAZOLONES | BAYER AG (DE) | 2024-03-27 | — | — | EP | disclosed |
| WO-1997035539-A2 | ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES | DU PONT PHARMACEUTICALS COMPANY (US) | 1997-10-02 | — | — | WO | disclosed |
| EP-0784612-A1 | UREA DERIVATIVES AND THEIR USE AS ACAT-INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-07-23 | — | — | EP | disclosed |
| EP-0764166-A1 | CORTICOTROPIN RELEASING FACTOR ANTAGONISTS | PFIZER INC. (US) | 1997-03-26 | — | — | EP | disclosed |
| WO-1996010559-A1 | UREA DERIVATIVES AND THEIR USE AS ACAT-INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-04-11 | — | — | WO | disclosed |
| WO-1995033750-A1 | CORTICOTROPIN RELEASING FACTOR ANTAGONISTS | PFIZER INC. (US) | 1995-12-14 | — | — | WO | disclosed |
| US-RE31244-E | Antihypertensive pyridylguanidine compounds | LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) | 1983-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130005743-A1 | New positive allosteric modulators of nicotinic acetylcholine receptor | CHRNG, CHRNA7, CHRNA1 | ALDH1A1 4066/4885TDP1 2407/4885TP53 3711/4885 |
| US-12613468-B2 | Method for forming patterned photoresist | CD44, PLOD1, ASIC1 | ALDH1A1 1113/4885TDP1 4824/4885TP53 3437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.